8-K: Alignment Healthcare Reports Strong 2023 Revenue Growth, Provides Positive 2024 Outlook

Alignment Healthcare announced a 27.2% increase in full-year 2023 revenue to $1.82 billion and projects continued growth in 2024 with adjusted EBITDA breakeven at the midpoint of the outlook ranges.

Summary

• Alignment Healthcare reported its financial results for the fourth quarter and full year ended December 31, 2023.
• The company's full-year 2023 total revenue reached $1.82 billion, a 27.2% increase year-over-year.
• Health plan membership grew to 119,200 by the end of 2023, a 21.1% increase year-over-year.
• Membership growth accelerated after the annual enrollment period, reaching a 44% year-over-year increase as of January 1.
• For the fourth quarter of 2023, total revenue was $465.4 million, a 28.6% increase year-over-year.
• The company reported a full-year adjusted gross profit of $208.8 million and an adjusted EBITDA loss of $35.3 million.
• Alignment Healthcare projects 2024 year-end health plan membership between 162,000 and 164,000, representing a 37% year-over-year growth.
• The company anticipates achieving adjusted EBITDA breakeven at the midpoint of its 2024 outlook ranges.

Sentiment

Score: 7

Explanation: The document presents a positive outlook with strong revenue and membership growth, but the company is still operating at a loss. The guidance for 2024 is positive, suggesting a potential for future profitability.

Positives

• The company achieved significant revenue growth of 27.2% for the full year 2023.
• Health plan membership saw substantial growth, increasing by 21.1% year-over-year to 119,200.
• Membership growth accelerated after the annual enrollment period, reaching 44% year-over-year as of January 1, 2024.
• The company is projecting strong membership growth for 2024, with a target of 162,000 to 164,000 members.
• Alignment Healthcare anticipates reaching adjusted EBITDA breakeven at the midpoint of its 2024 outlook ranges.

Negatives

• The company reported a net loss of $148.2 million for the full year 2023.
• The company reported an adjusted EBITDA loss of $35.3 million for the full year 2023.
• The company reported a loss from operations of $127.8 million for the full year 2023.
• The company's cash balance decreased from $409.5 million to $202.9 million year over year.

Risks

• The company's ability to attract new members and enter new markets is subject to governmental approvals.
• Maintaining a high rating on the Five Star Quality Rating System is crucial for the company's success.
• The company's performance is dependent on maintaining satisfactory relationships with care providers.
• Changes in laws and regulations applicable to the business model could impact the company.
• The company is exposed to risks related to its indebtedness, including potential rising interest rates.
• Market or industry conditions and receptivity to the company's technology and services could affect results.
• The company is subject to risks related to litigation or security incidents.
• Shortages of qualified personnel and related increases in labor costs could impact the company.

Future Outlook

Alignment Healthcare anticipates strong growth in 2024, projecting year-end health plan membership between 162,000 and 164,000 and adjusted EBITDA breakeven at the midpoint of the outlook ranges.

Management Comments

• Alignment Healthcare is built to thrive in the current Medicare Advantage market with our clinical framework and data-driven operations, said John Kao, founder and CEO.
• I am confident that the investments we have made to strengthen our visibility and control over medical costs and the member experience will continue to bolster growth in 2024 and beyond.

Industry Context

The results reflect the ongoing growth and competition within the Medicare Advantage market, where companies are focused on expanding membership and managing medical costs effectively. Alignment Healthcare's focus on clinical framework and data-driven operations aligns with industry trends towards value-based care.

Comparison to Industry Standards

• Alignment Healthcare's revenue growth of 27.2% is strong compared to some established players in the Medicare Advantage space, such as Humana and UnitedHealth, which have seen more moderate growth rates in recent years.
• However, the company's adjusted EBITDA loss of $35.3 million for the full year indicates that it is still in a growth phase and is not yet achieving profitability, unlike more mature companies in the sector.
• The medical benefits ratio of 88.5% is within the typical range for Medicare Advantage plans, but there is room for improvement to achieve better profitability.
• The projected membership growth of 37% for 2024 is aggressive and would position Alignment Healthcare as a fast-growing player in the market, if achieved.
• Companies like Clover Health and Oscar Health, which are also focused on technology-driven healthcare, are comparable in terms of their growth ambitions and challenges in achieving profitability.

Legal Proceedings

• The company incurred litigation costs related to a wage and hour class action lawsuit and legal action initiated by the company seeking injunctive relief prohibiting member solicitation in violation of CMS regulations.

Stakeholder Impact

• Shareholders will be encouraged by the strong revenue and membership growth, but concerned about the ongoing losses.
• Employees may be positively impacted by the company's growth and future prospects.
• Customers (members) should benefit from the company's focus on quality care and member experience.
• Providers will be impacted by the company's growth and its relationships with them.
• Creditors will be monitoring the company's financial performance and its ability to manage its debt.

Next Steps

• The company will host a conference call to discuss the results and outlook.
• The company will continue to focus on growing membership and managing medical costs.
• The company will work towards achieving adjusted EBITDA breakeven in 2024.

Key Dates

Keywords

Medicare Advantage, Health Plan, Healthcare, Financial Results, Membership Growth, Adjusted EBITDA, Revenue, Medical Benefits Ratio